Filing Details
- Accession Number:
- 0001181431-14-029004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-12 17:54:24
- Reporting Period:
- 2014-08-08
- Filing Date:
- 2014-08-12
- Accepted Time:
- 2014-08-12 17:54:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061027 | Sunesis Pharmaceuticals Inc | SNSS | Pharmaceutical Preparations (2834) | 943295878 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1288452 | Bay City Capital Llc | 750 Battery Street Suite 400 San Francisco CA 94111 | No | No | Yes | No | |
1401826 | Bay City Capital Fund V, L.p. | C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111 | No | No | Yes | No | |
1409813 | Bay City Capital Fund V Co-Investment Fund, L.p. | C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111 | No | No | Yes | No | |
1461543 | Bay City Capital Management V Llc | C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-08-08 | 662,378 | $6.62 | 4,975,709 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-08-08 | 12,622 | $6.62 | 4,963,087 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-08-11 | 31,009 | $6.90 | 4,932,078 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-08-11 | 591 | $6.90 | 4,931,487 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-08-12 | 36,406 | $6.77 | 4,895,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-08-12 | 694 | $6.77 | 4,894,387 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V.
- This transaction was executed in multiple trades at prices ranging from $6.62 to $6.71. The price reported above reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Represent securities held by Fund V, including indirect interests of BCC and Management V. BCC and Management V each disclaims beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
- Represent securities held by Co-Investment V, including indirect interests of BCC and Management V. BCC and Management V each disclaims beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
- This transaction was executed in multiple trades at prices ranging from $6.87 to $6.94. The price reported above reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $6.70 to $6.925. The price reported above reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.